|
|
|
|
| LEADER |
00000nab a2200000ua 4500 |
| 001 |
vtls010828745 |
| 003 |
SK-MaSNL |
| 005 |
20260303185020.0 |
| 008 |
230222s2008 xo |||||||||||||||||eng| |
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06exr
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab5u9h
|
| 035 |
|
|
|a (uuid)702e6238-cb14-4a9e-a93e-58cb785fabcc
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 100 |
1 |
|
|a Naidu, R.
|4 aut
|9 1215728
|
| 245 |
1 |
0 |
|a Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases
|c R. Naidu, C. H. Yip, N. A. Taib
|
| 700 |
1 |
|
|a Yip, C. H.
|4 aut
|9 1215729
|
| 700 |
1 |
|
|a Taib, N. A.
|4 aut
|9 1215730
|
| 773 |
0 |
|
|t Neoplasma : journal of experimental and clinical oncology
|g Roč. 55, č. 2 (2008), s. 87-95
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 958 |
|
|
|a article5
|
| 999 |
|
|
|c 2129402
|d 2131332
|
